Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of
Read moreCommunity pharmacy contractors (including head office staff) and community pharmacists are invited to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The
Read morePSNC, working with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback about EPS Paperless, Outcomes and Trackability. Please complete the short EPS survey here We would appreciate views from community pharmacy teams, including those working within multiple group head offices, who are requested to complete
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. MSN/2023/044 Tier 2 – medium impact Date of issue 6th April 2023 Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023 Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Estriol (Imvaggis®) 0.03mg pessary. MSN/2023/041 Tier 2 – medium impact Date of issue 6th April 2023 Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023 Alternative estriol vaginal products remain available, as does estradiol 10mcg vaginal tablets, and
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Oxycodone Hydrochloride 5mg/5ml Oral Solution. MSN/2023/042 Tier 2 – medium impact Date of issue 6th April 2023 Wockhardt is out of stock oxycodone 5mg/5ml oral solution until end of June 2023. Oxycodone 5mg/5ml oral solution from other manufacturers remains available but
Read moreIn response to a significant ongoing disruption to the supply of Clarithromycin 125mg/5ml and 250mg/5ml oral suspension, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 6 April 2023, SSP053 and SSP054 provides for the following: SSP053 – for every 5ml of Clarithromycin 125mg/5ml oral suspension,
Read moreNHS England (NHSE) has published a report on the anticoagulant audit* from the 2021/22 Pharmacy Quality Scheme (PQS). 9,303 community pharmacies participated in the anticoagulant audit and data was submitted for 131,526 patients. Pharmacy teams provided advice and made significant clinical intervention, preventing potential harm, for patients at increased risk of harm 33,173 times throughout
Read moreThe recruitment of pharmacists in Primary Care Networks (PCNs) has exacerbated a general shortage of pharmacists, says an independent review of Integrated Care Systems (ICSs) published today. The review, Rt Hon Patricia Hewitt, set out to consider the oversight and governance of ICS in England and the NHS targets and priorities for which Integrated Care
Read morePharmacy technicians are now able to perform blood pressure checks as part of the Hypertension Case-Finding Service and deliver the Smoking Cessation Service (SCS). The Drug Tariff has been amended, where necessary, to reflect this and includes the amendments to The Pharmaceutical Services (Advanced and Enhanced Services) (Amendment) (England) Directions 2023. The service specifications for
Read more
